In the gut, there are millions of bacteria and other micro-organisms,
collectively called the gut microbiome. Microbes in the gut are known to be important
modulators of the developing immune system.
In this month’s issue of JACI,
Sordillo and colleagues look at predictors of the gut microbiome in infancy (J Allergy Clin Immunol 2017; 139(2): 482-491). Microbes present in this early life window
may ultimately affect the risk of allergic disease later in childhood.
They looked at stool samples in over 300 infants born to
mothers in the Vitamin D Antenatal Asthma Reduction Trial (VDAART), a trial in
which pregnant women took vitamin D to see how it would impact their children’s
health. In the stool, they looked at the
bacterial genes to see what bacteria were present.
They found that race, mode of delivery, and formula-feeding
are associated with different composition of gut bacteria. Black race and caesarean section were
independent predictors of having lower levels of Bacteroides. This is
important because lower Bacteroides
abundance has already been associated with immune changes predisposing to
asthma and allergic disease. In
addition, formula feeding was linked to higher levels of Clostridia. Previous studies
have suggested a link between Clostridia
and development of atopic dermatitis, wheezing and allergic sensitization.
This study points out that factors with the potential to
increase allergic disease risk are also associated with alterations in the
infant gut microbiome, but there are still a lot of unanswered questions. Do these factors (race, mode of delivery,
formula feeding) act via changes in the infant gut microbiome to increase
allergic disease risk? Do these changes
in the gut microbiome persist through childhood? Can breastfeeding change the microbiome and
reduce the risk of allergic disease?
Finally, can we figure out which species and subspecies are most closely
associated with these risks? Further research
is needed, but this study provides a meaningful step towards providing answers.